Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 10/20 | 0.43 |
| ▸ | CA2 | P00918 | 10/20 | 0.43 |
| ▸ | CA9 | Q16790 | 8/20 | 0.43 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA7 | P43166 | 3/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.43 |
| ▸ | CA3 | P07451 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
| ▸ | CA6 | P23280 | 2/20 | 0.43 |
| ▸ | CA5A | P35218 | 2/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6812402 | 1.00 | CA1 (0.43) | CA1CA2CA9CA12CA7 | |
| SCHEMBL16592979 | 0.79 | TSHR (0.40) | CA1CA2CA9CA12CA7 | |
| SCHEMBL17334638 | 0.77 | TSHR (0.65) | CA1CA2CA9CA12CA7 | |
| SCHEMBL20128970 | 0.77 | TSHR (0.65) | CA1CA2CA9CA12CA7 | |
| SCHEMBL15923362 | 0.77 | TSHR (0.65) | CA1CA2CA9CA12CA7 | |
| SCHEMBL20145734 | 0.77 | TSHR (0.65) | CA1CA2CA9CA12CA7 | |
| SCHEMBL2057201 | 0.77 | USP2 (0.46) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL9999947 | 0.76 | TSHR (0.56) | CA1CA2CA9CA12CA7 | |
| SCHEMBL15922913 | 0.76 | TSHR (0.62) | CA1CA2CA9CA12CA7 | |
| SCHEMBL20145782 | 0.76 | TSHR (0.56) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6835720-B2 | Sulfated drugs | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 2004-12-28 | — | — | US | disclosed |
| EP-0957107-B1 | NOVEL COMPOUNDS HAVING ANTIVIRAL ACTIVITY | NISSIN FOOD PRODUCTS LTD (JP) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003049672-A2 | METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS-MEDIATED DISEASE | MICROBIOTIX, INC. (US) | 2003-06-19 | — | — | WO | disclosed |
| WO-2003041639-A2 | METHODS AND COMPOSITIONS FOR TREATING ROTAVIRUS-MEDIATED DISEASE | MICROBIOTIX, INC. (US) | 2003-05-22 | — | — | WO | disclosed |
| US-20030073664-A1 | Novel compounds having antiviral activity | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 2003-04-17 | — | — | US | disclosed |
| US-6541461-B2 | Treating viral infection; obtain mamal, administer vircide, monitor response to viricide | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 2003-04-01 | — | — | US | disclosed |
| US-20020077472-A1 | Novel compounds having antiviral activity | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 2002-06-20 | — | — | US | disclosed |
| US-6337390-B1 | MONOSACCHARIDE LIPID LINKED TO ANOMERIC CARBON OF SIALIC ACID OR KDN | NISSAN FOOD PRODUCTS CO., LTD. (JP) | 2002-01-08 | — | — | US | disclosed |
| EP-0957107-A1 | NOVEL COMPOUNDS HAVING ANTIVIRAL ACTIVITY | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 1999-11-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077472-A1 | Novel compounds having antiviral activity | ST6GAL1, SIGLEC7, NEU2 | CA1 1970/4885CA2 3154/4885CA9 1356/4885 |
| US-20030073664-A1 | Novel compounds having antiviral activity | ST6GAL1, SIGLEC7, NEU2 | CA1 1970/4885CA2 3154/4885CA9 1356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.